Eyeworld

MAR 2013

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/115557

Contents of this Issue

Navigation

Page 45 of 234

WITHOUT SACRIFICING HEALING WITHOUT SACRIFICING HEALING Treat first with dual-action PROKERA : ® • The only FDA-cleared therapeutic device that reduces inflammation and promotes healing 1-8 • An active biological corneal bandage 4 • A therapeutic option for ocular surface diseases, such as keratitis 2 • Safe and effective with no risk of IOP spikes 1 • Reduces pain and restores the ocular surface without scarring 1-7 • Available as an in-office procedure (CPT Code 65778) We've got you covered Order Today Call 888-296-8858 Or visit prokerainfo.com www.biotissue.com 8305 NW 27th Street, STE 101 | Miami, FL | 33173 ©Bio-Tissue 2013. All rights reserved. References: 1. Pachigolla G, et al. Eye Contact Lens. 2009;35:72-75. 2. Sheha H, et al. Cornea. 2009;28:1118-1123. 3. Gomes JA, et al. Curr Opin Ophthalmol. 2005;16:233-240. 4. Shay E, et al. Cornea. 2010;29:359-361. 5. Kheirkhah A, et al. Arch Ophthalmol. 2008;126:1059-1066. 6. Shammas MC, et al. Am J Ophthalmol. 2010;149:203-213. 7. Shay E, et al. Invest Ophthalmol Vis Sci. 2011;52:2669-2678. 8. Lazarro DR. Eye Contact Lens. 2010;36:60-61. SM-037, Rev A, 02/20/2012

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - MAR 2013